Skip to main content
. 2022 May 16;23:407. doi: 10.1186/s13063-022-06370-1

Table 1.

Primary outcome—Desirability of Outcome Ranking (DOOR) Endpoint Scoring

Rank Alive How many of:
1) Clinical failure
2) Infectious complication
3) SAE or AE leading to study drug discontinuation
QoL
1 Yes 0 of 3 Tiebreaker based on net change in HRQoL score from baseline
2 Yes 1 of 3
3 Yes 2 of 3
4 Yes 3 of 3
5 No (Death) Any